1 / 3

Hydrogel-Based Drug Delivery System Market

Hydrogel-Based Drug Delivery System market size was valued at USD 6.7 billion in 2021 and is projected to reach around USD 11.5 billion in 2030 exhibiting a CAGR of 8.5% in the forecasted period.

vikas94
Download Presentation

Hydrogel-Based Drug Delivery System Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hydrogel-Based Drug Delivery System Market Latest Technological Innovations in Upcoming years 2023-2030 Hydrogel-Based Drug Delivery System market size was valued at USD 6.7 billion in 2021 and is projected to reach around USD 11.5 billion in 2030 exhibiting a CAGR of 8.5% in the forecasted period. The extensive use in drug delivery applications, remarkable physical properties, increasing shares of R&D-associated drug delivery systems are expected to upsurge the market growth. However, compatibility problem with a small category of medicines, extreme rate of hydrogel, and low-down mechanical power are the factors are anticipated to hinder the growth of the market in the forecasted period. Request Free Sample Copy of this Report@ https://wemarketresearch.com/reports/request- free-sample-pdf/hydrogel-based-drug-delivery-system-market/843 Rising investment and financing by prominent pharma companies in R&D activities in exploration of a new drug, delivery systems, and diagnostic is one of the significant factors estimated to drive the market for hydrogel-based drug delivery systems in upcoming years. The productivity of a pharma company is dependent on its capability to grow effective formulations. The pharma industry is extremely fragmented and competitive thereby substantial investments are made into R&D to endure in the market. Almost 15-20% of the yearly revenue of pharma companies is financed in R&D activities. Hydrogel has been a favourable drug delivery system due to its exceptional physical properties. The growing R&D activities associated with drug delivery systems are expected to drive the market. The positive results of clinical trials associated with hydrogel-based drug delivery systems are boosting pharma companies to finance in this targeted therapy. As per the NBCI report printed in 2019, the hydrogel was used for therapeutic or diagnostic purposes in around 223 clinical trials eliminating the contact lens trials. Out of the 223 clinical trials, hydrogel coil was used in 8 clinical trials, the bulk hydrogel was used in 166 clinical trials, and patch hydrogel was used in 99 clinical trials.The high price of hydrogels, little mechanical

  2. strength, and compatibility problems with some drugs are the factors expected to hinder its market growth in the long run. The World Health Organization stated COVID-19 a pandemic on March 11, 2020. As per the Coronavirus Disease (COVID-19), Weekly Epidemiological Update by the World Health Organization, above 409 million cases and 5.8 million deaths because of coronavirus disease (COVID-19) were informed up till 13th, February 2022 worldwide. The Covid-19 pandemic made the necessity for understanding biocompatible polymers as backing material for organized drug delivery specifically for organohydrogels. Numerous studies are showed for characterization of novel organohydrogel as a natural drug carrier or release material. For instance, in January 2021, investigators synthesized numerous new polymeric materials such as organohydrogels, hydrogels, and gels for examining their use as drug release systems. The study determined that organohydrogels can be used as drug carrier and precise drug release materials. Henceforth, the great R&D activities in the pandemic for understanding the possible use of hydrogels in drug delivery is positively impacting the market growth during the forecasted period. Secure A Copy Of The Premium Research Report@ https://wemarketresearch.com/purchase/hydrogel-based-drug-delivery-system- market/843?license=single Competitive Analysis GALDERMA, Blairex Laboratories, Inc., Johnson & Johnson, Bausch and Lomb, Medtronic, Ocular Therapeutix, Inc., Ferring B.V., Endo International plc, Akorn, Incorporated, Tolmar Pharmaceuticals, Inc. About We Market Research: WE MARKET RESEARCH is an established market analytics and research firm with a domain experience sprawling across different industries. We have been working on multi-county market studies right from our inception. Over the time, from our existence, we have gained laurels for our deep-rooted market studies and insightful analysis of different markets. Contact Us: We Market Research Phone: +1(650)-666-4592 Email: sales@wemarketresearch.com

  3. Web: https://wemarketresearch.com/

More Related